SCHEMBL9654941

SCHEMBL9654941

CCOc1ccc2c(O)c(OC)c(OC)c(O)c2c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 7/20 0.47
▸ ALDH1A1 P00352 5/20 0.47
▸ HSD17B10 Q99714 3/20 0.47
▸ KDM4E B2RXH2 7/20 0.44
▸ HPGD P15428 3/20 0.44
▸ NPC1 O15118 2/20 0.44
▸ RAB9A P51151 2/20 0.44
▸ TP53 P04637 2/20 0.44
▸ NQO1 P15559 1/20 0.43
▸ TUBB4A P04350 3/20 0.43
▸ TUBB P07437 3/20 0.43
▸ TUBA3C P0DPH7 3/20 0.43
▸ TUBA1B P68363 3/20 0.43
▸ TUBA4A P68366 3/20 0.43
▸ TUBB4B P68371 3/20 0.43
▸ TUBB3 Q13509 3/20 0.43
▸ TUBB2A Q13885 3/20 0.43
▸ TUBB8 Q3ZCM7 3/20 0.43
▸ TUBA3E Q6PEY2 3/20 0.43
▸ TUBA1A Q71U36 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9657047 0.91 ALDH1A1 (0.47) MAPTALDH1A1HSD17B10KDM4EHPGD
SCHEMBL9657865 0.86 MAPT (0.41) MAPTALDH1A1HSD17B10KDM4EHPGD
SCHEMBL9449015 0.83 MAPT (0.45) MAPTALDH1A1HSD17B10KDM4EHPGD
SCHEMBL11064590 0.82 MAPT (0.50) MAPTALDH1A1HSD17B10KDM4EHPGD
SCHEMBL9627800 0.79 ABCB11 (0.43) MAPTALDH1A1HSD17B10KDM4EHPGD
SCHEMBL9656740 0.79 MAPT (0.48) MAPTALDH1A1HSD17B10KDM4EHPGD
SCHEMBL9657675 0.77 NQO1 (0.44) MAPTALDH1A1HSD17B10KDM4EHPGD
SCHEMBL9628139 0.76 ABCB11 (0.46) MAPTALDH1A1HSD17B10KDM4EHPGD
SCHEMBL2022420 0.73 MAPT (0.49) MAPTALDH1A1HSD17B10KDM4EHPGD
SCHEMBL2023572 0.73 MAPT (0.49) MAPTALDH1A1HSD17B10KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5134161-A Enzyme inhibitors for skin disorders, antiinflammatory agents SYNTEX (U.S.A.) INC. (US) 1992-07-28 — — US disclosed
US-4786652-A TOPICAL ADMINISTRATION SYNTEX (U.S.A.) INC. (US) 1988-11-22 — — US disclosed
EP-0282006-A1 Naphtalene anti-psoriatic agents SYNTEX (U.S.A.) INC. (US) 1988-09-14 — — EP disclosed
Send feedback